Саридон

Quick links to important sections

Саридон

Selected form

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Саридон

Property Description
Active ingredients Acetaminophen, Propyphenazone, Caffeine
Form Tablet
Pharmacological class Non-opioid Analgesic, Antipyretic
Common use General, temporary relief of pain and fever
Origin Synthetic

What Type of Medicine is Саридон?

Саридон is classified as a Fixed-Dose Combination (FDC) compound, functioning primarily as a non-opioid analgesic and antipyretic medicine. This structural designation means the drug is a singular pharmaceutical preparation that integrates multiple active ingredients into one stable dosage form, which in this case is a tablet intended for oral administration. The strategic use of FDCs is clinically recognized in pain management; pharmacological principles suggest that combined agents acting via different mechanisms often achieve a synergistic benefit. This indicates that combining active pain relievers can enhance the therapeutic effect. Being a chemically synthetic product, Саридон’s identity is defined by its ability to modulate pain signaling and reduce elevated body temperature through its established multi-component design.

Active Composition and General Purpose

The distinguishing structure of Саридон is its specific three-part active formula: Acetaminophen (Paracetamol), Propyphenazone, and Caffeine. The general purpose of this combination analgesic is the comprehensive, temporary management of acute symptoms involving discomfort and fever. The core analgesic and antipyretic action is supplied by Acetaminophen, while Propyphenazone, a pyrazolone derivative, reinforces these effects. The inclusion of Caffeine, a xanthine derivative, is integrated as an adjuvant—a substance intended to enhance the overall effectiveness of the other analgesic ingredients. This structured blend is specifically formulated for a synergistic intervention against general acute symptoms.

What side effects are possible with Саридон?

Possible Side Effects and Safety Information

This fixed-dose combination analgesic contains paracetamol (acetaminophen), propyphenazone, and caffeine. The safety profile is structured around both common adverse events and significant regulatory concerns related to the combined formulation.

Adverse Reactions and System-Organ Classes

The most commonly reported adverse reactions involve the gastrointestinal system (e.g., abdominal pain, diarrhea) and the nervous system (e.g., restlessness, anxiety, nervousness, sleep disorders). Skin and subcutaneous tissue disorders, such as rashes and allergic reactions (erythema, urticaria), are also noted. In rare instances, cardiac effects like faster heartbeat (tachycardia) have been reported.

Serious and Clinically Significant Risks

Specific safety concerns are associated with the propyphenazone component, a pyrazolone derivative. Severe and potentially fatal reactions, although uncommon, include a risk of leukopenia (low white blood cell count) and asthma precipitation in susceptible individuals. Cases of serious skin reactions have also been reported with acetaminophen-containing products, requiring immediate discontinuation if symptoms such as reddening or blistering occur.

Safety Restrictions and Regulatory Context

Official documents indicate that the Fixed-Dose Combination (FDC) drug containing Саридон's ingredients was subject to a government review that deemed its combination to have no therapeutic justification and to pose a potential risk to human health. This determination led a government authority to ban the manufacture and sale of the FDC, although the status of this ban has been subject to legal challenge and specific exemptions have been granted. The ingredients must be used with particular caution in patients with impaired liver function, impaired kidney function, or a history of specific blood disorders (e.g., hematopoietic dysfunction) or asthma.

Overdose and Emergency Response

Overdose: What to Know and When to Seek Help

Overdose with this medication, primarily due to its paracetamol component, can be serious and potentially fatal if not treated promptly. It is critical to note that signs of toxicity, particularly liver damage, may be delayed, sometimes manifesting two to four days after the overdose event.

Immediate Action Required

Seek immediate medical attention or call a Poison Control Centre even if you feel well or do not notice any possible symptoms, such as increased sweating, nausea, vomiting, or stomach pain. The critical window for administering life-saving antidotes, such as N-acetylcysteine, is ideally within eight hours of ingestion.

Documented Overdose Effects

The most significant risk is severe liver damage (hepatocellular necrosis), which may progress to hepatic failure and coma. Symptoms are often initially non-specific but may include loss of appetite, vomiting, and abdominal discomfort. In rare cases, high cumulative doses or acute overdose have been associated with isolated reports of acute renal failure or kidney damage (analgesic nephropathy). The risk of poisoning may be higher in the presence of alcohol.

System Affected Primary Manifestations
Hepatic Necrosis, Impaired function, Potential for hepatic coma
Metabolic Metabolic acidosis, Hypokalemia
Renal Acute renal failure (isolated reports)

Therapeutic Uses of Саридон

The fixed-dose combination structure of Saridon is utilized to provide symptomatic support across relevant domains characterized by symptoms related to physical discomfort and systemic imbalance, such as elevated body temperature. It is commonly used when symptoms create noticeable physiological strain, offering support that helps ease the overall burden of discomfort.

The medication is applied within clinical settings that involve symptoms associated with acute or episodic changes, and is considered relevant for easing discomfort in conditions such as tension headaches, acute migraine pain, dental pain, musculoskeletal aches, and dysmenorrhea. This combination is commonly used for managing symptom clusters that may appear suddenly or fluctuate. It is also applied in addressing symptoms related to systemic imbalance, particularly elevated body temperature (fever) and associated body aches during episodes of seasonal illness.

“This combination is relevant in contexts involving heightened systemic burden where short-term symptomatic assistance is needed.”

This action may help patients cope more steadily with symptom fluctuations and supports general well-being during symptomatic phases.


Quick Fact: Relief for Acute Symptomatic Episodes Saridon is commonly used across conditions presenting with acute episodes of mild to moderate discomfort and fever, providing support that helps improve day-to-day comfort during symptomatic periods.

Regulatory References

  1. Philippine Food and Drug Administration (FDA) Verification Portal

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Саридон — Official Regulatory Information

The eligibility for Саридон (Acetaminophen/Propyphenazone/Caffeine) is strictly defined by regulatory documents, which establish absolute prohibitions (contraindications) and conditional use restrictions.

Eligibility Scope

Category Eligibility Status (As Stated in Regulatory Documents)
Populations for whom use is allowed Adults and Adolescents aged 12 years and older.
Populations for whom use is contraindicated Individuals with hypersensitivity to the active ingredients or related pyrazolones, and patients with severe impairment of the liver, kidneys, or heart.
Age-related eligibility rules Children under 12 years of age are contraindicated.
Condition-specific eligibility rules Use requires caution in non-severe Renal or Hepatic Insufficiency, Hyperthyroidism, Gilbert's Syndrome, or a history of asthma/chronic rhinitis.
Physiological Status Contraindications Use is contraindicated during breastfeeding and the third trimester of pregnancy; use is generally not recommended in presumed pregnancy.

Official Eligibility Statements

Absolute Contraindications are mandated for specific conditions, including G6PD deficiency, Severe Haemolytic Anemia, Granulocytopenia, and a history of recurrent peptic ulcer or gastrointestinal bleeding. Regulatory bodies enforce these exclusions to define populations where the use of this fixed-dose combination medicine is prohibited.

What should I know about interactions with other medicines?

The official regulatory profile for this combination product (Paracetamol, Propyphenazone, and Caffeine) documents specific interactions that may alter drug concentrations or lead to additive effects, requiring management constraints.

Interaction Scope

Medicinal product categories with documented interactions:

  • Anticoagulants (e.g., Warfarin) and other antiplatelet or thrombolytic drugs, which may increase the risk of bleeding or hemorrhage.
  • Enzyme Inducers (e.g., Phenytoin, Carbamazepine, Rifampicin, Barbiturates), which can increase the formation of potentially toxic metabolites of the Paracetamol component.
  • Other Painkillers containing Paracetamol, to prevent potential overdose and heightened risk of toxicity.
  • Lithium, as Caffeine can increase its elimination from the body, potentially reducing its effect.
  • Certain Antiepileptics (e.g., Phenytoin, Carbamazepine), where Caffeine may reduce the effectiveness of the seizure control medication.
  • Stimulant Drugs (e.g., Ephedrine, MAOIs), which may cause excessive stimulation, high blood pressure, and increased heart rate due to additive effects with the Caffeine component.

Specific interacting medicines (if explicitly listed):

  • Warfarin
  • Chloramphenicol (Paracetamol may prolong its elimination)
  • Zidovudine
  • Metoclopramide or Domperidone (may increase Paracetamol absorption)

Interaction-related restrictions:

  • Consumption of alcohol is discouraged due to an increased risk of liver toxicity related to the Paracetamol component.
  • Avoidance of other Paracetamol-containing products is required to prevent accidental overdose.
  • Patients with Glucose-6-phosphate dehydrogenase deficiency are noted in official labeling to avoid use.

Connection to the Overall Interaction Profile

The regulatory documents define this product's interaction structure around the combined risks of its three components, primarily focusing on managing the hepatotoxicity risk associated with the Paracetamol component when co-administered with enzyme-inducing substances or alcohol. Additional constraints are derived from Propyphenazone's potential to increase bleeding risk with anticoagulants, and the potential for increased central nervous system stimulation or altered drug clearance due to the Caffeine component.

Mechanism of Action

The mechanism of action for Саридон is based on the synergistic influence of its three active components across distinct, yet complementary, physiological pathways.

Dual Modulation of Pain and Temperature Mediators

The physiological mechanism involves targeting the Prostaglandin Synthesis Pathway. Acetaminophen and Propyphenazone both function to inhibit Cyclooxygenase (COX) enzymes, thereby reducing the synthesis of Prostaglandin E2 ( PGE2). This reduction occurs primarily in the hypothalamus to restore the hypothalamic temperature set-point, and centrally/peripherally to reduce the sensitization of nociceptors. Acetaminophen further modulates central pain signals through its metabolite AM404 by interacting with TRPV1 and CB1 receptors.

️ Adjuvant Action via the Adenosine System

The inclusion of Caffeine introduces a separate neuromodulatory domain that contributes to the drug’s overall mechanism of action. Caffeine acts as a non-selective antagonist at central and peripheral A1 and A2A adenosine receptors. By blocking the effects of endogenous adenosine—a compound that acts as a pro-nociceptive and CNS-depressant mediator—this mechanism provides a significant pharmacodynamic potentiation that lowers the threshold for the analgesic components, modulating the physiological transmission of nociceptive signals.


The combined result of inhibiting PGE2 and blocking adenosine signaling is a broad, simultaneous influence on the pathways responsible for thermal dysregulation and nociceptive signal transmission, resulting in linked physiological adjustments.

Dosage and Administration Information

Instruction Map: How to use Саридон — Administration Guidelines

This map details the instructions for using the combination analgesic Саридон and must not be construed as clinical advice.

Feature Standard Description
Route of administration: Oral administration only, via the tablet form.
Dosing schedule (Adults): A single dose is 1 to 2 tablets. The maximum stated total daily dose is 4 tablets over a 24-hour period.
Timing in relation to meals: Some instructions specify taking the dose on a full stomach (after food), while administration with water is universal.
Preparation requirements: Tablets must be swallowed whole with ample water or fluid. No breaking, crushing, or chewing is specified in the administration instructions.
Age-group administration rules: The product is not recommended for use in children under 12 years of age. Adolescents aged 12 to 16 years are limited to a 1 tablet single dose.
Missed-dose rules: The medication is used on an as-needed basis for acute symptoms; there is no defined procedure for a missed scheduled dose.
Special procedural conditions: Continuous use is restricted, typically not to exceed 3 consecutive days for fever or 5 days for pain without consultation.

Instruction Classifications (High-Level)

Classification Pattern/Basis
Administration method type: Oral
Frequency pattern: As-needed (PRN), with a required minimum 4 to 6-hour interval between doses.
Use-context constraints: Short-term use only (3-5 days maximum duration constraint).

Resulting Procedural Structure

Standard Step Sequence:

  • 1. Swallow the single dose (1–2 tablets) whole with water, preferably after a meal as specified in some instances.
  • 2. Observe a minimum of 4 to 6 hours before administering a repeat dose.
  • 3. Do not exceed the maximum daily dose limit of 4 tablets in any 24-hour period.
  • 4. Discontinue administration after 3 to 5 days of continuous use.

Connection to the overall use protocol: Established guidelines define the medication's use as an intermittent, short-term measure for acute symptomatic management. The protocol is governed by the minimum 4-to-6-hour dosing interval and the non-exceedable maximum daily dose, defining the standardized approach to its administration.

Recent Clinical Evidence

Recent Clinical Evidence Overview

Saridon is an analgesic formulation that combines three active ingredients: Propyphenazone, Paracetamol (Acetaminophen), and Caffeine. Clinical research has primarily focused on evaluating the benefits and speed of action of this combination in managing acute pain, particularly headache.


Findings on Acute Pain and Onset of Action

Research studies, including a pooled statistical analysis of trials involving patients with acute dentoalveolar pain (pain following dental surgery), explored the compound's performance relative to single-ingredient analgesics and placebo.

Area of Study Key Research Finding (Observed)
Onset of Action A faster onset of action was observed compared to paracetamol alone, aspirin, and placebo in specific timeframes (e.g., 30 and 60 minutes after dosing).
Pain Relief Total pain relief scores measured over a four-hour period were higher in the Saridon group compared with paracetamol, ibuprofen, aspirin, and placebo groups in the pooled analysis.

Combination Efficacy

The rationale for the combination is based on the distinct actions of its components. Propyphenazone is a non-steroidal anti-inflammatory drug (NSAID) component, Paracetamol provides analgesic and antipyretic effects, and Caffeine acts as an adjuvant. Studies suggest that the addition of caffeine may enhance the pain-relieving effects of paracetamol. However, evidence regarding the overall long-term safety of this specific combination remains more limited compared to better-established single-ingredient alternatives. Regulatory status and approved indications may vary across different countries and regions.

Frequently Asked Questions (FAQ)

Common questions about Саридон (FAQ)

Q: Is Саридон an anti-inflammatory medicine?

Official product information indicates that Саридон is classified as an analgesic (pain reliever) and an antipyretic (fever reducer). It contains Propyphenazone, which is described in some official documentation as having anti-inflammatory properties. The official description of the ingredients indicates that one component, Propyphenazone, contributes an anti-inflammatory action.


Q: How quickly does Саридон usually start working?

Clinical studies have examined the onset of action for this combination medication. Research has observed a faster start to pain relief for the combined product when compared to using paracetamol alone or compared to placebos in acute pain studies.


Q: How long do the effects of Саридон typically last?

Regulatory instructions for administering this medication advise observing a minimum interval of four to six hours between doses. This time frame is the mandatory minimum interval before a repeat dose may be considered.


Q: What kind of headaches is Саридон intended for?

According to official product information, Саридон is indicated for the relief of mild to severe headache. This may include common types of discomfort such as tension headaches. The medication is generally used for acute, temporary pain relief.


Q: Is it common for people to use Саридон for muscle aches?

Official indications for this product include the relief of various types of body pain. Propyphenazone, one of the active components, is specifically described in some regulatory texts as addressing muscle or peripheral pain.


Q: Can Саридон be used for pain relief other than headache?

Official product indications confirm that the medication can be used for more than just headaches. It is also indicated for the relief of pain associated with conditions like toothache and dysmenorrhea (menstrual cramps).


Q: What is the difference between Саридон and a single-ingredient painkiller?

Саридон is a Fixed-Dose Combination (FDC) compound containing three active ingredients: Paracetamol, Propyphenazone, and Caffeine. Regulatory documents describe this as a 'Triple Action' product. The combination is formulated so that the Caffeine component acts as an adjuvant, which is intended to enhance the pain-relieving effects of the other two analgesic ingredients.


Q: Is Саридон generally available without a prescription?

In many regions, regulatory agencies classify this medication as an OTC Drug, meaning it is available over-the-counter. The availability and exact regulatory classification (OTC or prescription) may vary by country or region.


Q: Is there a maximum number of days Саридон is typically used?

Official safety information and instructions for use state that the product is intended only for short-term management of symptoms. Official instructions specify that use should not exceed five consecutive days for pain, or three consecutive days for fever.


Q: Does Саридон cause drowsiness?

The active ingredients in the medication are generally not associated with causing sleepiness. However, the adverse event lists for this product include potential central nervous system effects, such as dizziness. The product is not labeled as a medication that causes drowsiness.


Q: Are stomach problems a frequent side effect of Саридон?

According to regulatory documents, adverse reactions involving the gastrointestinal system are among the commonly reported side effects. These reactions may include abdominal pain and diarrhea. If persistent stomach problems are experienced, individuals are advised to seek guidance from a healthcare provider.


Q: Can Саридон cause problems with sleep or insomnia?

Yes, the adverse reaction lists for this medication include reports of sleep disorders, nervousness, agitation, and insomnia. These effects are primarily linked to the stimulating properties of the Caffeine component in the formulation.


Q: What is the risk of dependence associated with Саридон?

Саридон is classified as a non-opioid pain reliever and is not associated with opioid dependence. However, there is a potential for analgesic overuse headache with long-term, continuous use, which is why official use is strictly limited to short term. Some risks of psychological dependence are related to the Caffeine component.


Q: Is Саридон appropriate for use by teenagers?

Official eligibility guidelines generally allow for the use of this product in adolescents aged 12 years and older. However, specific administration instructions apply to individuals between 12 and 16 years of age in certain regions.


Q: Why might a person need to check with a doctor before using Саридон?

Official guidelines state that consultation with a healthcare provider is advised for certain populations. This includes people who are pregnant or breastfeeding, those taking other medications, or individuals with pre-existing conditions affecting the liver, kidneys, or respiratory system, such as asthma or chronic rhinitis.


Q: Is Саридон safe to use for a hangover headache?

Official safety warnings explicitly advise against the consumption of alcohol while taking this medication due to the increased risk of liver toxicity related to the Paracetamol component. Use for alcohol-related symptoms is generally inconsistent with the established safety warnings against combining the medication with alcohol.

--zens

Q: What are the official sources describing the purpose of Саридон?

The purpose, indications, and usage constraints of Саридон are formally documented in official regulatory sources. These include Product Information sheets, Summaries of Product Characteristics (SmPC), and documentation issued by national drug regulatory agencies like the FDA or EMA-aligned bodies.


Q: Does medical research support the combination of ingredients in Саридон?

Yes, clinical studies have been conducted on this specific combination formulation. Research suggests that the combination is effective, with studies indicating a greater total pain relief score and a faster onset of action when compared to using the individual components alone.


Q: Are there different doses of Саридон available?

Regulatory documents refer to a single, fixed strength of the product containing 250 mg of Paracetamol, 150 mg of Propyphenazone, and 50 mg of Caffeine per tablet. Therefore, the medication is not generally manufactured in different strengths, though the single dose may vary between one or two tablets.


Q: What should a person do if they forget to take Саридон at the intended time?

Саридон is an acute-use medication taken on an as-needed (PRN) basis for symptoms. There is no defined procedure for a missed scheduled dose, as the drug is not taken on a fixed schedule. Instead, a person may take a dose when needed, provided the mandatory minimum time interval has passed since the last administration.


Q: Is Саридон considered safe for older adults?

Official guidance lists elderly people as a group who should consult with a doctor before taking this medicine. This is a common precaution mandated by regulatory bodies.


Q: Does Саридон interact with any common herbal supplements?

Official interaction statements broadly advise checking with a healthcare professional regarding all medications, including natural health products or herbal remedies, to determine if any interaction risks exist.


Q: Is it common for people to experience dizziness after taking Саридон?

Dizziness is listed as a potential side effect on the psychoneurological system within the official adverse reaction reports. If dizziness occurs or is bothersome, individuals are advised to seek guidance from a healthcare provider.


Q: How should Саридон be stored at home?

Official storage instructions advise keeping the medication in a cool, dry place and away from direct sunlight. It is essential that the product remains securely stored and out of the reach of children to prevent accidental ingestion.


Q: Is it possible to take Саридон if I am sensitive to aspirin?

The use of the drug may be restricted for individuals who have had asthma or other reactions triggered by antipyretic analgesics, which includes sensitivity to aspirin. Official guidance mandates caution, and individuals with this history should seek professional advice before use.


Q: What is the recommended period of use before consulting a doctor about continued pain?

Official patient advice recommends consulting with a healthcare provider if pain symptoms persist or worsen after taking the medication for more than five days. A similar check is recommended if fever symptoms continue beyond three days.


Q: Is Саридон available in liquid or injectable forms?

The official regulatory information specifies that the approved dosage form for this product is the tablet, which is intended for oral administration. The medication is not officially available in liquid or injectable forms.


Q: Why is the number of tablets in a pack often limited for Саридон?

Regulatory pack size limits are generally established to align with safety warnings concerning the maximum daily dose and the short-term use constraint (3-5 days). This is done to mitigate the potential risk of toxicity associated with long-term or high-dose use of the components.


Q: Is the formulation of Саридон consistent across different countries?

While the core fixed composition of Paracetamol, Propyphenazone, and Caffeine remains standard in regulatory documentation globally, the official regulatory status and approved indications for its use may vary from country to country.


Q: What should I look out for that indicates I am taking too much Саридон?

Signs of potential overdose may include symptoms such as increased sweating, nausea, vomiting, stomach pain, and loss of appetite. Due to the Paracetamol component, taking too much can potentially lead to severe liver damage. If an overdose is suspected, emergency medical assistance should be sought promptly.


Q: Are there any known food interactions with Саридон?

Official information advises patients to discuss any potential food interactions with a healthcare professional. General guidelines suggest avoiding fasting when taking the medication. It is also advised to avoid other Paracetamol-containing products.


Q: Does taking Саридон affect the results of any lab tests?

Yes, official warnings indicate that administration of therapeutic doses of the Paracetamol component may cause changes in certain laboratory results. Specifically, it can lead to the elevation of serum alanine aminotransferase (ALT), which is a liver enzyme.


Q: Does taking Саридон affect blood pressure?

Due to the Caffeine component, the medication can affect the cardiovascular system. Official warnings advise caution for patients with pre-existing cardiovascular disease. Monitoring of blood pressure may be necessary for these individuals during use.

How should Саридон be stored and disposed of?

How to Store and Dispose of Carisoprodol

Carisoprodol must be stored according to specific regulatory requirements to maintain its stability and prevent misuse as a Schedule IV controlled substance.


Storage and Handling

  • Temperature: Store at Controlled Room Temperature, ideally between 20 C and 25 C (68 F to 77 F).
  • Protection: Keep the medication in a tight container and protect it from excessive heat, freezing, and moisture.
  • Security: Store Carisoprodol in a safe place and out of the reach of children and others to prevent theft and misuse, which is mandatory for controlled substances.

Disposal Instructions

Consult a healthcare professional for specific disposal guidance for unused or expired medicine. The official rules recommend utilizing drug take-back programs or a mail-back envelope if available. If these options are unavailable, the medicine should be mixed with an unappealing substance, such as coffee grounds or dirt, placed in a sealed bag, and discarded in the household trash. Do not flush this medication down the toilet unless directed to do so.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Саридон found in:

A-Z Index: